Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06947447 · ClinicalTrials.gov registry record
WatchPAT SpO2 Validation Study
A clinical trial, sponsored by Itamar-Medical, Israel.
- Completed
- Registry status
- 24
- Enrollment target
NCT06947447: Completed study, sponsored by Itamar-Medical, Israel.
NCT06947447 is a clinical trial that has completed, run by Itamar-Medical, Israel. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06947447 has completed, sponsored by Itamar-Medical, Israel.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Validate the SpO2 accuracy of the WatchPAT compared to arterial blood CO-Oximetry
Primary Outcome
WatchPAT SpO2 accuracy performance over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.
Interventions
- DEVICE No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-04-21 |
| Est. Completion | 2025-05-02 |
What the finished NCT06947447 record still lists
NCT06947447 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT06947447 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06947447 about?
NCT06947447 is a clinical study titled "WatchPAT SpO2 Validation Study". Validate the SpO2 accuracy of the WatchPAT compared to arterial blood CO-Oximetry
What is the current status of trial NCT06947447?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2025-04-21. Estimated completion is 2025-05-02.
What interventions are being tested in trial NCT06947447?
The interventions under investigation include: No intervention (DEVICE).
Who is sponsoring clinical trial NCT06947447?
This trial is sponsored by Itamar-Medical, Israel, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI